Rhythm Pharmaceuticals, Inc. · NASDAQ:RYTM
Vanguard Capital Management LLC reported a 5.02% stake in Rhythm Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.02% stake in Rhythm Pharmaceuticals, Inc., 3,432,949 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.02%
- Shares
- 3,432,949
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.02% | 3,432,949 |
Source
Related
- Rhythm Pharmaceuticals, Inc.
- Vanguard Capital Management LLC
- Rhythm Pharmaceuticals, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Meeker David P · Sep 14, 2026
- Form 4 · Smith Hunter C · Sep 1, 2026
- Form 4 · Shulman Joseph · Aug 17, 2026
- Form 4 · Garfield Alastair · Aug 17, 2026